Breakthrough Discovery: New Liver Cell Type May Combat Severe Liver Disease, Study Finds
Researchers have identified a novel liver cell type that may protect against metabolic dysfunction-associated steatohepatitis (MASH), a severe liver d...
Researchers have identified a novel liver cell type that may protect against metabolic dysfunction-associated steatohepatitis (MASH), a severe liver d...
Survodutide, a next-generation GLP-1 drug, achieved a 16.6% reduction in body weight in a Phase 3 trial, outperforming placebo by over 13%. The dual-a...